Cargando…

Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications

Immunoglobulin light chain amyloidosis (AL) is an indolent plasma cell disorder characterized by free immunoglobulin light chain (FLC) misfolding and amyloid fibril deposition. The cytogenetic pattern of AL shows profound similarity with that of other plasma cell disorders but harbors distinct featu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Linchun, Su, Yongzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290569/ https://www.ncbi.nlm.nih.gov/pubmed/34284823 http://dx.doi.org/10.1186/s40164-021-00236-z

Ejemplares similares

Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach
por: Hwa, Yi L., et al.
Publicado: (2019)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021
por: Hasib Sidiqi, M., et al.
Publicado: (2021)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
por: Morisaki, Shinsuke, et al.
Publicado: (2021)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018
por: Gertz, Morie A.
Publicado: (2018)

Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
por: Swaminathan, Renugadevi, et al.
Publicado: (2021)

Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
por: Ozercan, Mubin, et al.
Publicado: (2021)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
por: Yan, Jipeng, et al.
Publicado: (2022)

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Simultaneous Clinical Presentation of Renal Cell Carcinoma and Immunoglobulin Light Chain Amyloidosis
por: Prasad, Bhanu, et al.
Publicado: (2018)

Differences in Immunoglobulin Light Chain Species Found in Urinary Exosomes in Light Chain Amyloidosis (AL)
por: Ramirez-Alvarado, Marina, et al.
Publicado: (2012)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
por: Jensen, Christopher E., et al.
Publicado: (2022)

Importance of FISH genetics in light chain amyloidosis
por: Gertz, Morie A., et al.
Publicado: (2017)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Editorial: Advances in the understanding of pathogenesis, diagnosis, and therapy of light chain amyloidosis
por: Bhutani, Divaya, et al.
Publicado: (2023)

Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis
por: Poshusta, Tanya L., et al.
Publicado: (2009)

Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group
por: Maurer, Mathew S., et al.
Publicado: (2022)

Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency
por: Guo, Yong-mei, et al.
Publicado: (2019)

Amyloid cranial polyneuropathy: A rare neurological presentation of immunoglobulin light‐chain amyloidosis
por: Agarwal, Abhinav, et al.
Publicado: (2021)

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
por: Vergaro, Giuseppe, et al.
Publicado: (2021)

(99m)Tc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis
por: Quarta, Candida Cristina, et al.
Publicado: (2021)

Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis
por: Ravichandran, Sriram, et al.
Publicado: (2022)

T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab‐based therapy
por: Wang, Yujia, et al.
Publicado: (2021)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

Peritumoral Immunoglobulin M Lambda Light Chain Amyloidosis in a Patient With Advanced Follicular Lymphoma
por: Shah, Kalpesh, et al.
Publicado: (2022)

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
por: Lama, Niki, et al.
Publicado: (2022)

Immunoglobulin Light Chain (AL) Amyloidosis Preceding Marginal Zone Lymphoma: A Case Report
por: Doshi, Krishna, et al.
Publicado: (2022)

Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
por: Stelmach-Gołdyś, Agnieszka, et al.
Publicado: (2022)

Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
por: Warsame, R, et al.
Publicado: (2015)

Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient
por: Swuec, Paolo, et al.
Publicado: (2019)

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
por: Fraser, Cameron S., et al.
Publicado: (2022)

Prognostic value of right ventricular global longitudinal strain in patients with immunoglobulin light-chain cardiac amyloidosis
por: Usuku, Hiroki, et al.
Publicado: (2023)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury
por: Crees, Zachary D., et al.
Publicado: (2022)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lm5bqkdjuqueo280em1hruilpp